Weight loss increased serum adiponectin but decreased lipid levels in obese subjects whose body mass index was lower than 30 kg/m2

Nutrition Research

Volumn 31, Issue 5, 2011, Pages 378-386

  Lang, Hui Fen ^a,b   Chou, Ching Ya ^a,b   Sheu, Wanye Huey Herng ^b   Lin, Jin Yuarn ^a  

^a NATIONAL CHUNG HSING UNIVERSITY   (Taiwan)

^b TAICHUNG VETERANS GENERAL HOSPITAL   (Taiwan)

Author keywords

8 Week weight control program; Adiponectin body mass index; Human; Obese subjects; Tumor necrosis factor

Indexed keywords

ADIPONECTIN; CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL; TUMOR NECROSIS FACTOR ALPHA;

ADULT; AEROBIC EXERCISE; ARTICLE; BODY MASS; CHOLESTEROL BLOOD LEVEL; CLINICAL ARTICLE; DIASTOLIC BLOOD PRESSURE; DIET THERAPY; FEMALE; HUMAN; LIPID COMPOSITION; MALE; OBESITY; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; SYSTOLIC BLOOD PRESSURE; THERAPY EFFECT; WAIST CIRCUMFERENCE; WEIGHT CONTROL; WEIGHT REDUCTION;

ADIPONECTIN; ADIPOSE TISSUE; ADULT; BLOOD PRESSURE; BODY MASS INDEX; BODY WEIGHTS AND MEASURES; DIET, REDUCING; EXERCISE; FEMALE; HUMANS; LIPIDS; MALE; MIDDLE AGED; OBESITY; TUMOR NECROSIS FACTOR-ALPHA; WEIGHT LOSS;

EID: 79957785406     PISSN: 02715317     EISSN: 18790739     Source Type: Journal    
DOI: 10.1016/j.nutres.2011.04.004     Document Type: Article

References (38)

1. Ford E.S., Williamson D.F., Liu S. Weight change and diabetes incidence: findings from a national cohort of US adults. Am J Epidemiol 1997, 146:214-222.
2. Segersvard R., Tsai J.A., Herrington M.K., Wang F. Obesity alters cytokine gene expression and promotes liver injury in rats with acute pancreatitis. Obesity 2008, 16:23-28.
3. Hsieh M.H., Ho C.K., Hou N.J., Hsieh M.Y., Lin W.Y., Yang J.F., et al. Abnormal liver function test results are related to metabolic syndrome and BMI in Taiwanese adults without chronic hepatitis B or C. Int J Obes 2009, 33:1309-1317.
4. Sumarac-Dumanovic M., Stevanovic D., Ljubic A., Jorga J., Simic M., Stamenkovic-Pejkovic D., et al. Increased activity of interleukin-23/interleukin-17 pro-inflammatory axis in obese women. Int J Obes 2009, 33:151-156.
5. Tataranni P.A., Ortega E. A burning question: does an adipokine-induced activation of the immune system mediate the effect of overnutrition on type 2 diabetes?. Diabetes 2005, 54:917-927.
6. Fantuzzi G. Adipose tissue, adipokines, and inflammation. J Allergy Clin Immunol 2005, 115:911-919.
7. Schafler A., Scholmerich J., Salzberger B. Adipose tissue as an immunological organ: Toll-like receptors, C1q/TNFs and CTRPs. Trends Immunol 2007, 28:393-399.
8. Shimada K., Miyazaki T., Daida H. Adiponectin and atherosclerotic disease. Clin Chim Acta 2004, 344:1-12.
9. Swardfager W., Lanctot K., Rothenburg L., Wong A., Cappell J., Herrmann N. A meta-analysis of cytokines in Alzheimer's disease. Biol Psychiatry 2010, 68:930-941.
10. Diez J.J., Iglesias P. The role of the novel adiponectin-derived hormone adiponectin in human disease. Eur J Endocrinol 2003, 148:293-300.
11. Kumada M., Kihara S., Ouchi N., Kobayashi H., Okamoto Y., Ohashi K., et al. Adiponectin specifically increased tissue inhibitor of metalloproteinase-1 through interleukin-10 expression in human macrophages. Circulation 2004, 109:2046-2049.
12. Whitehead J.P., Richards A.A., Hickman I.J., Macdonald G.A., Prins J.B. Adiponectin-a key adipokine in the metabolic syndrome. Diabetes Obes Metab 2006, 8:264-280.
13. Shin M.J., Kim O.Y., Koh S.J., Chae J.S., Kim J.Y., Jang Y., et al. Modest weight loss does not increase plasma adiponectin levels: effects of weight loss on C-reactive protein and DNA damage. Nutr Res 2006, 26:391-396.
14. Renaldi O., Pramono B., Sinorita H., Purnomo L.B., Asdie R.H., Asdie A.H. Hypoadiponectinemia: a risk for metabolic syndrome. Acta Med Indones 2009, 41:20-24.
15. Shargorodsky M., Boaz M., Goldberg Y., Matas Z., Gavish D., Fux A., et al. Adiponectin and vascular properties in obese patients: is it a novel biomarker of early atherosclerosis?. Int J Obes 2009, 33:553-558.
16. Norata G.D., Baragetti I., Raselli S., Stucchi A., Garlaschelli K., Vettoretti S., et al. Plasma adiponectin levels in chronic kidney disease patients: relation with molecular inflammatory profile and metabolic status. Nutr Metab Cardiovasc Dis 2010, 20:56-63.
17. Tsataanis C., Zacharioudaki V., Androulidaki A., Dermitzaki E., Charalampopoulos I., Minas V., et al. Adiponectin induces TNF-alpha and IL-6 in macrophages and promotes tolerance to itself and other pro-inflammatory stimuli. Biochem Biophys Res Commun 2005, 335:1254-1263.
18. Culling K.S., Neil H.A.W., Gilbert M., Frayn K.N. Effects of short-term low- and high-carbohydrate diets on postprandial metabolism in non-diabetic and diabetic subjects. Nutr Metab Cardiovasc Dis 2009, 19:345-351.
19. Expert Panel W.H.O. Appropriate body-mass index for Asian populations and its implications for policy and intervention strategies. Lancet 2004, 363:157-163.
20. Lundgren J.D., Malcolm B., Binks M., O'Neil P.M. Remission of metabolic syndrome following a 15-week low-calorie lifestyle change program for weight loss. Int J Obes 2009, 33:144-150.
21. Lin J.Y., Lu S., Liou Y.L., Liou H.L. Antioxidant and hypolipidaemic effects of a novel yam-boxthorn noodle in an in vivo murine model. Food Chem 2006, 94:377-384.
22. Lin J.Y., Li C.Y., Hwang I.F. Characterization of the pigment components in red cabbage (Brassica oleracea L. var.) juice and their anti-inflammatory effects on LPS-stimulated murine splenocytes. Food Chem 2008, 109:771-781.
23. Hellenius M.L., de Faire U., Berglund B., Hamsten A., Krakau I. Diet and exercise are equally effective in reducing risk for cardiovascular disease. Results of a randomized controlled study in men with slightly to moderately raised cardiovascular risk factors. Atherosclerosis 1993, 103:81-91.
24. Suastika K. Update in the management of obesity. Acta Med Indones 2006, 38:231-237.
25. Baratta R., Amato S., Degano C., Farina M.G., Patane G., Vigneri R., et al. Adiponectin relationship with lipid metabolism is independent of body fat mass: evidence from both cross-sectional and intervention studies. J Clin Endocrinol Metab 2004, 89:2665-2671.
26. Bruun J.M., Lihn A.S., Verdich C., Pedersen S.B., Toubro S., Astrup A., et al. Regulation of adiponectin by adipose tissue-derived cytokines: in vivo and in vitro investigations in humans. Am J Physiol Endocrinol Metab 2003, 285:E527-E533.
27. O'Rourke R.W., Metcalf M.D., White A.E., Madala A., Winters B.R., Maizlin I.I., et al. Depot-specific differences in inflammatory mediators and a role for NK cells and IFN-γ in inflammation in human adipose tissue. Int J Obes 2009, 33:978-990.
28. Lin J.Y., Li C.Y. Proteinaceous constituents of red cabbage juice increase IL-10, but decrease TNF-α secretions using LPS-stimulated mouse splenocytes. J Food Drug Anal 2010, 18:15-23.
29. Kos K., Wong S.P.Y., Huda M.S.B., Cakir M., Jernas M., Carlsson L., et al. In humans the adiponectin receptor R2 is expressed predominantly in adipose tissue and linked to the adipose tissue expression of MMIF-1. Diabetes Obes Metab 2010, 12:360-363.
30. Polyzos S.A., Kountouras J., Zavos C., Tsiaousi E. The role of adiponectin in the pathogenesis and treatment of non-alcoholic fatty liver disease. Diabetes Obes Metab 2010, 12:365-383.
31. Xydakis A.M., Case C.C., Jones P.H., Hoogeveen R.C., Liu M.Y., Smith E.O., et al. Adiponectin, inflammation, and the expression of the metabolic syndrome in obese individuals: the impact of rapid weight loss through caloric restriction. J Clin Endocrinol Metab 2004, 89:2697-2703.
32. Ouchi N., Kihara S., Arita Y., Okamoto Y., Maeda K., Kuriyama H., et al. Adiponectin, an adipocyte-derived plasma protein, inhibits endothelial NF-kappaB signaling through a cAMP-dependent pathway. Circulation 2000, 102:1296-1301.
33. Giannopoulou I., Fernhall B., Carhart R., Weinstock R.S., Baynard T., Figueroa A., et al. Effects of diet and/or exercise on the adipocytokine and inflammatory cytokine levels of postmenopausal women with type 2 diabetes. Metabolism 2005, 54:866-875.
34. Polak J., Klimcakova E., Moro C., Viguerie N., Berlan M., Hejnova J., et al. Effect of aerobic training on plasma levels and subcutaneous abdominal adipose tissue gene expression of adiponectin, leptin, interleukin 6, and tumor necrosis factor alpha in obese women. Metabolism 2006, 55:1375-1381.
35. Esposito K., Pontillo A., Di Palo C., Giugliano G., Masella M., Marfella R., et al. Effect of weight loss and lifestyle changes on vascular inflammatory markers in obese women: a randomized trial. JAMA 2003, 289:1799-1804.
36. Ryan A.S., Nicklas B.J., Berman D.M., Elahi D. Adiponectin levels do not change with moderate dietary induced weight loss and exercise in obese postmenopausal women. Int J Obes Relat Metab Disord 2003, 27:1066-1071.
37. Nicklas B.J., You T., Pahor M. Behavioral treatments for chronic systemic inflammation: effects of dietary weight loss and exercise training. CMAJ 2005, 172:1199-1209.
38. Niswender K. Diabetes and obesity: therapeutic targeting and risk reduction-a complex interplay. Diabetes Obes Metab 2010, 12:267-287.